
When You Diagnose (or Suspect) Cancer: 3 Reasons to Refer Your Patients to RCCA
“What happens next?” “Where should I go for treatment?” They are questions physicians often hear after informing a patient that they have identified confirmed or
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Ovarian cancer is a type of gynecologic cancer that forms in the ovaries, fallopian tubes, or peritoneum. If you or a loved one has recently been diagnosed with ovarian cancer, turn to Regional Cancer Care Associates (RCCA) for comprehensive care. RCCA is one of the nation’s largest networks of cancer specialists, providing the latest evidence-based treatments for patients with ovarian cancer in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area. Learn more about ovarian cancer, including its symptoms, stages, and treatment options.
A woman’s reproductive system includes the ovaries and fallopian tubes. When abnormal cells grow uncontrollably in one of these organs, it is known as ovarian cancer. These abnormal cells can divide and form tumors, which destroy healthy tissue and can spread — or metastasize — to other parts of the body.
Although the ovaries and fallopian tubes are different organs, they are closely connected and share similar epithelial cells, so cancers arising in either organ are often grouped together under the term ovarian cancer.
Ovarian cancer is the fifth leading cause of cancer deaths among women in the United States. The high death toll for the disease is related to the fact that it has vague symptoms, which often result in ovarian cancer not being diagnosed until it has spread, making it more difficult to treat successfully. According to the American Cancer Society, about 21,010 women in the United States will receive a diagnosis of ovarian cancer in 2026.
To determine the best treatment plan for a patient’s cancer, it’s necessary to identify the type. There are three main types of ovarian cancer, which are categorized by the cell type where the cancer originates. They are:
Epithelial ovarian tumors are the most common type, accounting for around 90% of all malignant ovarian cancers. These tumors form in the thin layer of tissue that covers the outer layer of the ovaries (epithelial tissue) or related tissues in the fallopian tubes. The most common subtype is serous carcinoma, which may be either aggressive and fast growing (high grade) or slower growing (low grade).
Germ cell tumors are rare tumors that form in egg-producing cells. They are often benign, although some may be malignant. These tumors are most often diagnosed in younger patients. Subtypes include teratomas, dysgerminomas, and yolk sac tumors.
Stromal tumors begin in the ovaries’ structural or connective hormone-producing tissues, which produce estrogen and progesterone. They are uncommon, often cause hormone-related symptoms, and are typically diagnosed earlier than epithelial tumors. Subtypes include granulosa cell tumors, which can cause symptoms like abnormal bleeding, and Sertoli-Leydig cell tumors, which are extremely rare and may produce male hormones.
Ovarian cancer is notorious for not causing many symptoms until later stages, limiting early detection. However, when ovarian cancer symptoms do appear, they can include:
Although many women who do not have ovarian cancer will experience these symptoms at some point, if the symptoms are new, chronic, severe, or get progressively worse, women should speak with their doctor to determine the cause.
Researchers have identified several ovarian cancer risk factors. They include:
Other risk factors include endometriosis, polyendocrine metabolic ovarian syndrome (PMOS), or other types of cancer. Having one or more of these risk factors doesn’t automatically mean that a woman will develop ovarian cancer. However, it’s smart to pay special attention to symptoms of potential ovarian cancer if you have multiple risk factors.
Diagnosing ovarian cancer involves a thorough clinical assessment with screenings and other tools to rule out other potential conditions and to confirm the presence of cancer. The diagnostic process includes:
Typically, initial diagnostic tests are performed by a gynecologist or primary care physician. If those tests suggest or confirm cancer, the patient will be referred to oncology specialists for further testing.
When a patient receives a diagnosis of ovarian cancer, the cancer will be given a stage. Ovarian cancer stages include:
These stages also have subtypes. The stage and subtype of the cancer help determine the best treatment option and play a role in determining the overall survival rate for women with that stage and subtype. For example, the five-year survival rate for women diagnosed with localized ovarian cancer (when the cancer has not spread outside the ovaries) is 92%. If the cancer metastasizes to distant organs, the percentage falls to 32%. It is important to remember, that these statistics reflects outcomes for a group of patients. Individual patients may have a much different prognosis – or outlook – based on their age, overall health, and other factors.
Cancer treatment is not one-size-fits-all. Treatment plans are highly personalized based on many factors, including the type, stage, and tumor characteristics of the cancer, as well as the patient’s health history and treatment goals. Common treatment options for ovarian cancer include:
Other options, such as hormone therapy, immunotherapy, and radiation therapy, may also be used to support other treatment options or as alternatives to them. RCCA oncologists will collaborate to determine the best treatment method for each patient. RCCA also provides side effects management and other helpful resources to help patients undergoing cancer treatment.
Women seeking high-quality ovarian cancer treatment can find it at Regional Cancer Care Associates. We have an experienced multidisciplinary team that treats various cancer types and blood disorders with personalized treatment plans. With more than 20 convenient locations near you throughout New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, patients can choose where they want to receive care. To learn more about ovarian cancer treatment near you, contact us or request an appointment today.
What is ovarian cancer?
Ovarian cancer is a condition that occurs when abnormal cells grow uncontrollably in the ovaries or fallopian tubes.
What are the most common ovarian cancer symptoms?
The most common ovarian cancer symptoms include bloating, pelvic or abdominal pain, feeling full quickly while eating, a frequent or urgent need to urinate, and other urinary changes.
Can ovarian cancer symptoms be mistaken for digestive or urinary problems?
Yes. Many symptoms of ovarian cancer, such as feeling full quickly after eating, decreased appetite, and a frequent or urgent need to urinate, also can be symptoms of digestive or urinary conditions, which can make prompt identification of ovarian cancer difficult.
What are the main types of ovarian tumors?
The main types of ovarian tumors include:
Who is at higher risk of ovarian cancer?
People at a higher risk of ovarian cancer include women over age 55, women with a strong family history of ovarian cancer, or those with certain inherited gene mutations, such as BRCA1 or BRCA2.
How is ovarian cancer diagnosed?
Ovarian cancer is diagnosed through a thorough clinical assessment, which includes a physical exam, transvaginal ultrasound, blood tests, other imaging scans, and a biopsy.
What do the stages of ovarian cancer mean?
The stages of ovarian cancer tell you the size and nature of the tumor and where it has spread. They help oncologists develop treatment plans and determine the prognosis – or outlook – for the patient.
What ovarian cancer treatment options are available?
Common ovarian cancer treatment options include surgery, chemotherapy, and targeted therapy. Hormone therapy, immunotherapy, and radiation therapy may also be used.
At Regional Cancer Care Associates (RCCA), we feature the best of modern oncologic medicine. We meet the highest standard of cancer care in both quality and safety. At the same time, we lead with our hearts, offering an environment characterized by compassion. We focus on you, individually, and work with you and your family to ensure your care is second to none.
For more information, please call (844) 346-7222. You can schedule an appointment by calling the RCCA location nearest you.

“What happens next?” “Where should I go for treatment?” They are questions physicians often hear after informing a patient that they have identified confirmed or

Early detection is essential to breast cancer treatment. The sooner cancer is diagnosed, the easier it will be to treat and avoid long-term health consequences.

Prostate cancer affects more American men than any other cancer, with the exception of skin cancer. In addition to the impact of the cancer itself,
When standard cancer treatments aren’t providing the results you want, clinical trials may offer hope. Our physicians use clinical trials to study new treatments, helping transform cancer care for the better. You can enroll in a clinical trial to try groundbreaking treatment plans at zero cost to you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.